An announcement from Bio-Rad Laboratories ( ($BIO) ) is now available. On August 26, 2025, Bio-Rad Laboratories hosted an informational webinar on ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of four new Droplet Digital™ PCR (ddPCR ...

The QX Continuum Droplet Digital™ PCR (ddPCR™) System* combines a simple workflow with sensitivity and precision, empowering researchers to explore a wide range of applications. From detecting subtle ...

Dr. Karlin-Neumann shared a few noteworthy applications of droplet digital PCR that include the measurement of rare HIV DNA in patients for effective combination antiretroviral therapy (cART) and ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that in two studies published this month, ahead of ...

In this study, we tested the ability of droplet digital PCR (ddPCR) to quantitatively measure levels of circulating BRAF and NRAS mutant DNA in the plasma of metastatic melanoma patients undergoing ...

Bio-Rad Laboratories’ Droplet Digital™ PCR (ddPCR) system partitions the test sample into 20,000 droplets; after amplification, the droplets containing the target sequence are detected using ...

Digital Droplet PCR (ddPCR) is a method for performing digital PCR use microfluidic water-oil emulsion technology. By utilizing microfluidics and fractionating DNA samples into nanoliter droplets , ...

“This collaboration advances Bio-Rad’s strategy to establish Droplet Digital PCR as a foundational technology by providing researchers and laboratories with high-value assays across a variety ...

HERCULES, Calif., July 07, 2025--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of four new ...